
GSK reports promising early results in ovarian and womb cancer drug trial
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug
The Guardian
Trump threatens 100% tariff on US drug makers that don’t strike deals to lower prices
New tax will hit branded drugs and active ingredients while exempting generics for at least one year
The Guardian
Some medicines could run out in weeks or even days, NHS England head warns
Jim Mackey tells LBC phone-in he is ‘really worried’ about supply issues amid US-Iran war
The Guardian
Mounjaro maker wants NHS drug price rises in return for more investment in UK
US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers
The Guardian
UK ‘weeks away’ from medicine shortages if Iran war continues, experts say
Concern that supply chain disruption could hit health essentials – and prices – from painkillers to cancer treatment
The Guardian
Chinese-owned Syngenta to build new £100m bioscience hub in UK
Agrichemical group will open a research centre in Berkshire, in a move hailed by UK government as ‘clear’ vote of confidence
The Guardian
Patients face long journeys for medicines as pharmacies cut weekend hours
More than 20% of weekend availability lost in England since 2022, forcing some to turn to A&E, says national association
The Guardian
Sir Ronnie Hampel obituary
Chief executive and chairman of ICI in the 1990s who oversaw the creation of the pharmaceutical company Zeneca
The Guardian
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn
UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds
The Guardian
Weight-loss drugs alone will not solve UK’s obesity crisis, says Chris Whitty
Chief medical adviser warns of side-effects and calls for action on junk food advertising and making food healthier
The Guardian